{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:14:24Z","timestamp":1789892064586,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60250-1","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:10:14Z","timestamp":1748621414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base"],"prefix":"10.1038","volume":"16","author":[{"given":"Sieglinde","family":"De Cae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Van Molle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2588-9750","authenticated-orcid":false,"given":"Loes","family":"van Schie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-2361","authenticated-orcid":false,"given":"Sophie R.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4754-4772","authenticated-orcid":false,"given":"Nincy","family":"Debeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahine","family":"Lameire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Nerinckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-4603","authenticated-orcid":false,"given":"Kenny","family":"Roose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Fijalkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackeline Cecilia Zavala","family":"Marchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Venneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1303-1629","authenticated-orcid":false,"given":"Koen","family":"Sedeyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Mujanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ballegeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Vanheerswynghels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"De Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Demol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Zuallaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vanhaverbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza Hassanzadeh","family":"Ghassabeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-7929","authenticated-orcid":false,"given":"Chiara","family":"Lonigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viki","family":"Bockstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-7312","authenticated-orcid":false,"given":"Rana","family":"Abdelnabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-2163","authenticated-orcid":false,"given":"Susan","family":"Marqusee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-6917","authenticated-orcid":false,"given":"Nico","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-4102","authenticated-orcid":false,"given":"Han","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-6965","authenticated-orcid":false,"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-1984","authenticated-orcid":false,"given":"Bert","family":"Schepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"60250_CR1","doi-asserted-by":"publisher","first-page":"109822","DOI":"10.1016\/j.celrep.2021.109822","volume":"37","author":"AK Wheatley","year":"2021","unstructured":"Wheatley, A. K. et al. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep. 37, 109822 (2021).","journal-title":"Cell Rep."},{"key":"60250_CR2","doi-asserted-by":"publisher","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell, https:\/\/doi.org\/10.1016\/j.cell.2020.09.037 (2020).","DOI":"10.1016\/j.cell.2020.09.037"},{"key":"60250_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36561-6","volume":"14","author":"D Planas","year":"2023","unstructured":"Planas, D. et al. Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies. Nat. Commun. 14, 824 (2023).","journal-title":"Nat. Commun."},{"key":"60250_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cmi.2024.04.012","volume":"30","author":"D Focosi","year":"2024","unstructured":"Focosi, D., Franchini, M., Casadevall, A. & Maggi, F. An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2. Clin. Microbiol. Infect. 30, 999\u20131006 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"60250_CR5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70362","volume":"10","author":"E Dodero-Rojas","year":"2021","unstructured":"Dodero-Rojas, E., Onuchic, J. N. & Whitford, P. C. Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion. Elife 10, e70362 (2021).","journal-title":"Elife"},{"key":"60250_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790415","volume":"12","author":"N Vanderheijden","year":"2021","unstructured":"Vanderheijden, N. et al. Functional analysis of human and feline coronavirus cross-reactive antibodies directed against the SARS-CoV-2 fusion peptide. Front. Immunol. 12, 790415 (2021).","journal-title":"Front. Immunol."},{"key":"60250_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2022.10.010","volume":"31","author":"C Dacon","year":"2023","unstructured":"Dacon, C. et al. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe 31, 97\u2013111.e12 (2023).","journal-title":"Cell Host Microbe"},{"key":"60250_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.abj3321","volume":"373","author":"D Pinto","year":"2021","unstructured":"Pinto, D. et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science 373, 1109\u20131116 (2021).","journal-title":"Science"},{"key":"60250_CR9","doi-asserted-by":"publisher","first-page":"e1010691","DOI":"10.1371\/journal.ppat.1010691","volume":"18","author":"MS Piepenbrink","year":"2022","unstructured":"Piepenbrink, M. S. et al. Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody. PLOS Pathog. 18, e1010691 (2022).","journal-title":"PLOS Pathog."},{"key":"60250_CR10","doi-asserted-by":"publisher","unstructured":"Andreano, E. et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell, https:\/\/doi.org\/10.1016\/j.cell.2021.02.035 (2021).","DOI":"10.1016\/j.cell.2021.02.035"},{"key":"60250_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73027","volume":"10","author":"FD Mast","year":"2021","unstructured":"Mast, F. D. et al. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. Elife 10, e73027 (2021).","journal-title":"Elife"},{"key":"60250_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s42003-022-03866-z","volume":"5","author":"MA Rossotti","year":"2022","unstructured":"Rossotti, M. A. et al. Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models. Commun. Biol. 5, 933 (2022).","journal-title":"Commun. Biol."},{"key":"60250_CR13","doi-asserted-by":"publisher","first-page":"eabl9929","DOI":"10.1126\/sciimmunol.abl9929","volume":"7","author":"V Fumagalli","year":"2022","unstructured":"Fumagalli, V. et al. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci. Immunol. 7, eabl9929 (2022).","journal-title":"Sci. Immunol."},{"key":"60250_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100521","volume":"14","author":"B Yan","year":"2021","unstructured":"Yan, B., Yang, J., Xie, Y. & Tang, X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ. J. 14, 100521 (2021).","journal-title":"World Allergy Organ. J."},{"key":"60250_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nbt.1601","volume":"28","author":"J Zalevsky","year":"2010","unstructured":"Zalevsky, J. et al. Enhanced antibody half-life improves in vivo activity. Nat. Biotechnol. 28, 157\u2013159 (2010).","journal-title":"Nat. Biotechnol."},{"key":"60250_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","volume":"597","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97\u2013102 (2021).","journal-title":"Nature"},{"key":"60250_CR17","doi-asserted-by":"publisher","first-page":"eabi7826","DOI":"10.1126\/scitranslmed.abi7826","volume":"13","author":"B Schepens","year":"2021","unstructured":"Schepens, B. et al. An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Sci. Transl. Med. 13, eabi7826 (2021).","journal-title":"Sci. Transl. Med."},{"key":"60250_CR18","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039.e15 (2019).","journal-title":"Cell"},{"key":"60250_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"60250_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120\u2013124 (2020).","journal-title":"Nature"},{"key":"60250_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6230","volume":"371","author":"P-A Koenig","year":"2021","unstructured":"Koenig, P.-A. et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 371, eabe6230 (2021).","journal-title":"Science"},{"key":"60250_CR22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","volume":"6","author":"L Casalino","year":"2020","unstructured":"Casalino, L. et al. Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein. ACS Cent. Sci. 6, 1722\u20131734 (2020).","journal-title":"ACS Cent. Sci."},{"key":"60250_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo3153","volume":"8","author":"TC Marcink","year":"2022","unstructured":"Marcink, T. C. et al. Intermediates in SARS-CoV-2 spike-mediated cell entry. Sci. Adv. 8, eabo3153 (2022).","journal-title":"Sci. Adv."},{"key":"60250_CR24","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1074\/jbc.M601174200","volume":"281","author":"S Hakansson-McReynolds","year":"2006","unstructured":"Hakansson-McReynolds, S., Jiang, S., Rong, L. & Caffrey, M. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state. J. Biol. Chem. 281, 11965\u201311971 (2006).","journal-title":"J. Biol. Chem."},{"key":"60250_CR25","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1126\/science.3381086","volume":"240","author":"JS Richardson","year":"1988","unstructured":"Richardson, J. S. & Richardson, D. C. Amino acid preferences for specific locations at the ends of alpha helices. Science 240, 1648\u20131652 (1988).","journal-title":"Science"},{"key":"60250_CR26","doi-asserted-by":"publisher","first-page":"e1010828","DOI":"10.1371\/journal.ppat.1010828","volume":"18","author":"SN Seifert","year":"2022","unstructured":"Seifert, S. N. et al. An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. PLoS Pathog. 18, e1010828 (2022).","journal-title":"PLoS Pathog."},{"key":"60250_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41594-022-00735-5","volume":"29","author":"SM Costello","year":"2022","unstructured":"Costello, S. M. et al. The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes. Nat. Struct. Mol. Biol. 29, 229\u2013238 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60250_CR28","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.abe3354","volume":"370","author":"MA Tortorici","year":"2020","unstructured":"Tortorici, M. A. et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science 370, 950\u2013957 (2020).","journal-title":"Science"},{"key":"60250_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63646","volume":"10","author":"PV Raghuvamsi","year":"2021","unstructured":"Raghuvamsi, P. V. et al. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets. eLife 10, e63646 (2021).","journal-title":"eLife"},{"key":"60250_CR30","doi-asserted-by":"publisher","first-page":"eadf1421","DOI":"10.1126\/sciimmunol.adf1421","volume":"7","author":"JE Bowen","year":"2022","unstructured":"Bowen, J. E. et al. SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci. Immunol. 7, eadf1421 (2022).","journal-title":"Sci. Immunol."},{"key":"60250_CR31","doi-asserted-by":"publisher","first-page":"eabf1906","DOI":"10.1126\/scitranslmed.abf1906","volume":"13","author":"BE Jones","year":"2021","unstructured":"Jones, B. E. et al. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci. Transl. Med. 13, eabf1906 (2021).","journal-title":"Sci. Transl. Med."},{"key":"60250_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110812","volume":"39","author":"K Westendorf","year":"2022","unstructured":"Westendorf, K. et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep. 39, 110812 (2022).","journal-title":"Cell Rep."},{"key":"60250_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20602-5","volume":"12","author":"C Kim","year":"2021","unstructured":"Kim, C. et al. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein. Nat. Commun. 12, 288 (2021).","journal-title":"Nat. Commun."},{"key":"60250_CR34","doi-asserted-by":"publisher","unstructured":"Cao, Y. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature https:\/\/doi.org\/10.1038\/s41586-022-05644-7 (2022).","DOI":"10.1038\/s41586-022-05644-7"},{"key":"60250_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.chom.2022.11.012","volume":"31","author":"P Qu","year":"2023","unstructured":"Qu, P. et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 31, 9\u201317.e3 (2023).","journal-title":"Cell Host Microbe"},{"key":"60250_CR36","doi-asserted-by":"publisher","first-page":"eabm0899","DOI":"10.1126\/scitranslmed.abm0899","volume":"14","author":"H-Y Huang","year":"2022","unstructured":"Huang, H.-Y. et al. Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models. Sci. Transl. Med. 14, eabm0899 (2022).","journal-title":"Sci. Transl. Med."},{"key":"60250_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.abd5223","volume":"370","author":"B Turo\u0148ov\u00e1","year":"2020","unstructured":"Turo\u0148ov\u00e1, B. et al. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science 370, 203\u2013208 (2020).","journal-title":"Science"},{"key":"60250_CR38","doi-asserted-by":"publisher","unstructured":"Planchais, C. et al. Broad sarbecovirus neutralization by combined memory B-cell antibodies to ancestral SARS-CoV-2. iScience 110354, https:\/\/doi.org\/10.1016\/j.isci.2024.110354 (2024).","DOI":"10.1016\/j.isci.2024.110354"},{"key":"60250_CR39","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.abe1107","volume":"370","author":"KW Ng","year":"2020","unstructured":"Ng, K. W. et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 370, 1339\u20131343 (2020).","journal-title":"Science"},{"key":"60250_CR40","doi-asserted-by":"publisher","first-page":"eabn3715","DOI":"10.1126\/scitranslmed.abn3715","volume":"14","author":"KW Ng","year":"2022","unstructured":"Ng, K. W. et al. SARS-CoV-2 S2\u2013targeted vaccination elicits broadly neutralizing antibodies. Sci. Transl. Med. 14, eabn3715 (2022).","journal-title":"Sci. Transl. Med."},{"key":"60250_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","volume":"183","author":"H Yao","year":"2020","unstructured":"Yao, H. et al. Molecular architecture of the SARS-CoV-2 Virus. Cell 183, 730\u2013738.e13 (2020).","journal-title":"Cell"},{"key":"60250_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11373-005-9004-3","volume":"12","author":"S-C Lai","year":"2005","unstructured":"Lai, S.-C. et al. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV). J. Biomed. Sci. 12, 711\u2013727 (2005).","journal-title":"J. Biomed. Sci."},{"key":"60250_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157597","volume":"7","author":"W-L Wu","year":"2022","unstructured":"Wu, W.-L. et al. Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants. JCI Insight 7, e157597 (2022).","journal-title":"JCI Insight"},{"key":"60250_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","volume":"80","author":"K-M Lip","year":"2006","unstructured":"Lip, K.-M. et al. Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus. J. Virol. 80, 941\u2013950 (2006).","journal-title":"J. Virol."},{"key":"60250_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-023-06273-4","volume":"619","author":"W Shi","year":"2023","unstructured":"Shi, W. et al. Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane. Nature 619, 403\u2013409 (2023).","journal-title":"Nature"},{"key":"60250_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213332120","volume":"120","author":"Y Song","year":"2023","unstructured":"Song, Y. et al. In situ architecture and membrane fusion of SARS-CoV-2 Delta variant. Proc. Natl Acad. Sci. USA. 120, e2213332120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"60250_CR47","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA. 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"60250_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025858","volume":"6","author":"M Berger Rentsch","year":"2011","unstructured":"Berger Rentsch, M. & Zimmer, G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS ONE 6, e25858 (2011).","journal-title":"PLoS ONE"},{"key":"60250_CR49","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"60250_CR50","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","volume":"181","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181, 1004\u20131015.e15 (2020).","journal-title":"Cell"},{"key":"60250_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"60250_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"60250_CR53","unstructured":"R Foundation for Statistical Computing, Vienna, Austria. R: a language and environment for statistical computing (R Foundation for Statistical Computing, 2024)."},{"key":"60250_CR54","unstructured":"Pinheiro, Bates & R Core Team. nlme: linear and nonlinear mixed effects models (R Core Team, 2023)."},{"key":"60250_CR55","doi-asserted-by":"publisher","unstructured":"Mixed-effects models in S and S-PLUS (Springer-Verlag, 2000). https:\/\/doi.org\/10.1007\/b98882.","DOI":"10.1007\/b98882"},{"key":"60250_CR56","unstructured":"Kuhn, M., Weston, S., Wing, J., Forester, J. & Thaler, T. contrast: A Collection of Contrast Methods. R package version 0.24.2, https:\/\/CRAN.R-project.org\/package=contrast (2022)."},{"key":"60250_CR57","unstructured":"Harrell, F. E. Jr. rms: Regression Modeling Strategies. R package version 6.8-0, https:\/\/CRAN.R-project.org\/package=rms (2024)."},{"key":"60250_CR58","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bimj.200810425","volume":"50","author":"T Hothorn","year":"2008","unstructured":"Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general parametric models. Biometrical J. 50, 346\u2013363 (2008).","journal-title":"Biometrical J."},{"key":"60250_CR59","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1021\/ac201729v","volume":"83","author":"M Guttman","year":"2011","unstructured":"Guttman, M., Scian, M. & Lee, K. K. Tracking hydrogen\/deuterium exchange at glycan sites in glycoproteins by mass spectrometry. Anal. Chem. 83, 7492\u20137499 (2011).","journal-title":"Anal. Chem."},{"key":"60250_CR60","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","volume":"16","author":"GR Masson","year":"2019","unstructured":"Masson, G. R. et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat. Methods 16, 595\u2013602 (2019).","journal-title":"Nat. Methods"},{"key":"60250_CR61","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1074\/jbc.M112.424150","volume":"288","author":"DV da Silva","year":"2013","unstructured":"da Silva, D. V., Nordholm, J., Madjo, U., Pfeiffer, A. & Daniels, R. Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains. J. Biol. Chem. 288, 644\u2013653 (2013).","journal-title":"J. Biol. Chem."},{"key":"60250_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D. Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"60250_CR63","doi-asserted-by":"crossref","unstructured":"Vonrhein, C. et al. Advances in automated data analysis and processing within autoPROC, combined with improved characterisation, mitigation and visualisation of the anisotropy of diffraction limits using STARANISO. Acta Crystallogr. Sect. A 74, a360\u2013a360 (2018).","DOI":"10.1107\/S010876731809640X"},{"key":"60250_CR64","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1107\/S2059798322007987","volume":"78","author":"E Krissinel","year":"2022","unstructured":"Krissinel, E. et al. CCP4 Cloud for structure determination and project management in macromolecular crystallography. Acta Cryst. D. 78, 1079\u20131089 (2022).","journal-title":"Acta Cryst. D."},{"key":"60250_CR65","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"60250_CR66","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D. Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"60250_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"60250_CR68","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"60250_CR69","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1021\/acs.jpcb.0c04553","volume":"124","author":"H Woo","year":"2020","unstructured":"Woo, H. et al. Developing a fully glycosylated full-length SARS-CoV-2 spike protein model in a viral membrane. J. Phys. Chem. B 124, 7128\u20137137 (2020).","journal-title":"J. Phys. Chem. B"},{"key":"60250_CR70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112703118","volume":"118","author":"L Tai","year":"2021","unstructured":"Tai, L. et al. Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein. Proc. Natl Acad. Sci. USA 118, e2112703118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60250-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60250-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60250-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T17:01:52Z","timestamp":1748624512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60250-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60250"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60250-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.D.C., B.S., X.S., L.v.S., W.N., K.R., N.C., G.H.G., H.R., I.V.M., V.B., and R.M. are named as inventors on patent application WO2023\/222825 A1 \u201cSarbecovirus Spike S2 Subunit Binders\u201d. N.C. and X.S. are scientific founders of ExeVir Bio BV and are in receipt of ExeVir Bio BV share options. T.V. and V.B. are and M.R. and C.L. were employed by ExeVir Bio BV and are in receipt of ExeVir Bio BV share options. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5040"}}